Authors: KAUFMANN GR DUNCOMBE C ZAUNDERS J CUNNINGHAM P COOPER D

Citation: Gr. Kaufmann et al., PRIMARY HIV-1 INFECTION - A REVIEW OF CLINICAL MANIFESTATIONS, IMMUNOLOGICAL AND VIROLOGICAL CHANGES, AIDS patient care and STDs, 12(10), 1998, pp. 759-767

Authors: KAUFMANN GR DUNCOMBE C CUNNINGHAM P BEVERIDGE A CARR A SAYER D FRENCH M COOPER DA

Citation: Gr. Kaufmann et al., TREATMENT RESPONSE AND DURABILITY OF A DOUBLE PROTEASE INHIBITOR THERAPY WITH SAQUINAVIR AND RITONAVIR IN AN OBSERVATIONAL COHORT OF HIV-1-INFECTED INDIVIDUALS, AIDS, 12(13), 1998, pp. 1625-1630

Authors: KAUFMANN GR VOZEH S WENK M HAEFELI WE

Citation: Gr. Kaufmann et al., SAFETY AND EFFICACY OF A 2-COMPARTMENT BAYESIAN FEEDBACK PROGRAM FOR THERAPEUTIC TOBRAMYCIN MONITORING IN THE DAILY CLINICAL USE AND COMPARISON WITH A NON-BAYESIAN ONE-COMPARTMENT MODEL, Therapeutic drug monitoring, 20(2), 1998, pp. 172-180

Authors: KAUFMANN GR WENK M TAESCHNER W PETERLI B GYR K MEYER UA HAEFELI WE

Citation: Gr. Kaufmann et al., N-ACETYLTRANSFERASE-2 POLYMORPHISM IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical pharmacology and therapeutics, 60(1), 1996, pp. 62-67